Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BJDX Bluejay Diagnostics	$1.36 +3.8%	$1.60	$1.26 ▼ $18.25	$2.03M	0.48	5.15 million shs	209,242 shs
HSCS HeartSciences	$3.38 -3.4%	$3.76	$2.36 ▼ $6.47	$7.69M	2.56	136,404 shs	84,226 shs
PAVM PAVmed	$0.45 -1.4%	$0.57	$0.30 ▼ $1.90	$7.69M	1.08	260,247 shs	116,161 shs
SINT Sintx Technologies	$3.04 -0.3%	$2.99	$1.71 ▼ $8.60	$8.38M	0.65	65,682 shs	37,387 shs

The Best High-Yield Dividend Stocks for 2025

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BJDX Bluejay Diagnostics	0.00%	-2.86%	-15.53%	-24.02%	-90.83%
HSCS HeartSciences	0.00%	-5.85%	-18.75%	+3.68%	+1.50%
PAVM PAVmed	0.00%	-1.55%	-25.03%	-30.69%	-37.52%
SINT Sintx Technologies	0.00%	+5.19%	+9.75%	-3.80%	-27.79%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BJDX Bluejay Diagnostics	0.6844 of 5 stars	0.0	3.0	0.0	3.1	0.0	0.6
HSCS HeartSciences	3.3742 of 5 stars	3.5	5.0	0.0	3.6	0.8	0.6
PAVM PAVmed	4.6 of 5 stars	3.5	5.0	4.3	2.6	0.0	1.9
SINT Sintx Technologies	2.6703 of 5 stars	3.5	4.0	0.0	2.4	1.7	0.0

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BJDX Bluejay Diagnostics	0.00	N/A	N/A	N/A
HSCS HeartSciences	3.00	Buy	$13.00	284.62% Upside
PAVM PAVmed	3.00	Buy	$19.00	4,124.10% Upside
SINT Sintx Technologies	3.00	Buy	$28.00	821.05% Upside

Current Analyst Ratings Breakdown

Latest BJDX, HSCS, SINT, and PAVM Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
6/6/2025	PAVM PAVmed	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$19.50 ➝ $19.00
5/30/2025	SINT Sintx Technologies	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$30.00 ➝ $28.00

(Data available from 8/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BJDX Bluejay Diagnostics	N/A	N/A	N/A	N/A	$3.54 per share	N/A
HSCS HeartSciences	$4.35K	1,768.48	N/A	N/A	$0.18 per share	18.78
PAVM PAVmed	$2.99M	2.57	N/A	N/A	($0.92) per share	-0.49
SINT Sintx Technologies	$1.23M	6.82	N/A	N/A	$2.90 per share	1.05

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BJDX Bluejay Diagnostics	-$7.72M	-$125.15	N/A	∞	N/A	N/A	-362.07%	-299.10%	N/A
HSCS HeartSciences	-$8.77M	-$9.36	N/A	N/A	N/A	N/A	-293.60%	-135.39%	9/11/2025 (Estimated)
PAVM PAVmed	$39.79M	$1.16	0.39	N/A	N/A	7,144.80%	N/A	-21.77%	N/A
SINT Sintx Technologies	-$11.02M	-$50.56	N/A	∞	N/A	-674.05%	-241.74%	-117.00%	N/A

Latest BJDX, HSCS, SINT, and PAVM Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
9/11/2025	N/A	HSCS HeartSciences	-$2.41	N/A	N/A	N/A	N/A	N/A
8/14/2025	Q2 2025	SINT Sintx Technologies	-$0.79	-$0.91	-$0.12	-$0.91	$0.40 million	$0.15 million
8/7/2025	Q2 2025	BJDX Bluejay Diagnostics	N/A	-$1.41	N/A	-$1.41	N/A	N/A
7/24/2025	Q4 2025	HSCS HeartSciences	-$2.51	-$1.88	+$0.63	-$1.88	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BJDX Bluejay Diagnostics	N/A	N/A	N/A	N/A	N/A
HSCS HeartSciences	N/A	N/A	N/A	N/A	N/A
PAVM PAVmed	N/A	N/A	N/A	N/A	N/A
SINT Sintx Technologies	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BJDX Bluejay Diagnostics	N/A	4.56	4.56
HSCS HeartSciences	N/A	0.59	0.41
PAVM PAVmed	N/A	0.37	0.37
SINT Sintx Technologies	N/A	3.44	3.25

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BJDX Bluejay Diagnostics	18.47%
HSCS HeartSciences	17.24%
PAVM PAVmed	19.93%
SINT Sintx Technologies	18.38%

Insider Ownership

Company	Insider Ownership
BJDX Bluejay Diagnostics	0.08%
HSCS HeartSciences	1.80%
PAVM PAVmed	7.30%
SINT Sintx Technologies	4.08%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BJDX Bluejay Diagnostics	9	1.49 million	1.49 million	Not Optionable
HSCS HeartSciences	10	2.28 million	2.24 million	Not Optionable
PAVM PAVmed	90	17.09 million	15.85 million	Optionable
SINT Sintx Technologies	40	2.76 million	2.64 million	Not Optionable

BJDX, HSCS, SINT, and PAVM Headlines

Recent News About These Companies

Sintx Technologies issues business update following strategic realignment

August 15 at 6:15 PM | msn.com

SINTX Technologies Issues Business Update Following Strategic Realignment, Leadership Expansion, and SiNAPTIC Acquisition

August 15 at 8:02 AM | globenewswire.com

Sintx Technologies (SINT) Expected to Announce Quarterly Earnings on Tuesday

August 10, 2025 | americanbankingnews.com

SINTX Technologies Expands Silicon Nitride Platform into Hybrid CFR-PEKK Trauma Plates

August 4, 2025 | globenewswire.com

SINTX Technologies Submits FDA 510(k) for Silicon Nitride Foot & Ankle Medical Devices

July 22, 2025 | taiwannews.com.twT

Sintx Technologies, Inc. (SINT) - Yahoo Finance

June 27, 2025 | finance.yahoo.com

SINTX Technologies Acquires Surgical Business Assets Of SiNAPTIC Holdings - Nasdaq

June 26, 2025 | nasdaq.com

SINTX Technologies stock jumps on deal to acquire SiNAPTIC surgical assets

June 24, 2025 | msn.com

SINTX Technologies Acquires SiNAPTIC Surgical Assets and IP to Expand into $1.3B Foot and Ankle Fusion Market

June 24, 2025 | globenewswire.com

Mark Lewis Anderson Acquires 10,000 Shares of Sintx Technologies, Inc. (NASDAQ:SINT) Stock

June 24, 2025 | insidertrades.com

SINTX Technologies Announces Strategic Vision Focused on Expansion Across Key Sectors

June 13, 2025 | tmcnet.com

Sintx Technologies Draws Heavy Retail Buzz On New Patent Push, Subsidiary

May 23, 2025 | msn.com

SINTX Technologies Announces Patent Issuance and Formation of Subsidiary to Advance Antimicrobial Applications in the Agribiotech Market

May 22, 2025 | globenewswire.com

SiNtx Technologies Inc.

May 19, 2025 | marketwatch.com

SiNtx Technologies Inc.

May 19, 2025 | marketwatch.com

SINTX Technologies, Inc.: SINTX Technologies Provides Business Update Highlighting Strategic Focus to Medical Device Commercialization

May 16, 2025 | finanznachrichten.de

Mark Lewis Anderson Purchases 5,000 Shares of Sintx Technologies, Inc. (NASDAQ:SINT) Stock

May 15, 2025 | insidertrades.com

SINTX Technologies Provides Business Update Highlighting Strategic Focus to Medical Device Commercialization

May 15, 2025 | globenewswire.com

Sintx Technologies, Inc. (NASDAQ:SINT) Insider Gregg R. Honigblum Buys 10,000 Shares

May 1, 2025 | insidertrades.com

Sintx Technologies Appoints Five New Board Directors

April 8, 2025 | tipranks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

BJDX, HSCS, SINT, and PAVM Company Descriptions

Bluejay Diagnostics NASDAQ:BJDX

$1.36 +0.05 (+3.82%)

Closing price 08/15/2025 04:00 PM Eastern

Extended Trading

$1.37 +0.01 (+0.66%)

As of 08/15/2025 07:57 PM Eastern

Bluejay Diagnostics, Inc., a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, it develops IL-6 for the monitoring of disease progression in critical care; as well as hsTNT/I and NT-proBNP for the monitoring of patients acuity with chest pain. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.

HeartSciences NASDAQ:HSCS

$3.38 -0.12 (-3.43%)

Closing price 08/15/2025 04:00 PM Eastern

Extended Trading

$3.38 0.00 (0.00%)

As of 08/15/2025 07:56 PM Eastern

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

PAVmed NASDAQ:PAVM

$0.45 -0.01 (-1.40%)

Closing price 08/15/2025 04:00 PM Eastern

Extended Trading

$0.45 +0.00 (+0.04%)

As of 08/15/2025 06:44 PM Eastern

PAVmed Inc. focuses on acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck. Its product pipeline also comprises EsoCure EsoCure Esophageal Ablation Device for treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.

Sintx Technologies NASDAQ:SINT

$3.04 -0.01 (-0.33%)

Closing price 08/15/2025 04:00 PM Eastern

Extended Trading

$3.03 -0.01 (-0.33%)

As of 08/15/2025 07:48 PM Eastern

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time